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Abstract
Objective:  To  assess  the  accuracy  of  Diffusion-Weighted  MR  Imaging  (DW-MRI)  at  3-Teslas  (3  T)
with a  b-value  of  2000  s/mm2 (b-2000  DW-MRI)  to  detect  prostate  cancer  (PCa)  and  to  describe
the histological  features  of  missed  tumors.
Methods:  Prior  to  radical  prostatectomy,  35  patients  with  a  mean  age  of  64  ±  6.2  years  old
[51—77 years  old]  had  a  b-2000  DW-MRI  at  3-T,  without  rectal  coil  (acquisition  time:  2  min,  15  s),Prostate  cancer and were  analysed  on  an  eight-sector  basis  by  two  independent  readers  blinded  to  the  rest  of
the multiparametric-MRI  protocol.  Pathological  tumor  foci  were  matched  with  high  intensity
focal areas  on  MRI  and  correlated  for  Gleason  score,  sector  location  and  largest  axial  diameter.
Results: Of  the  280  sectors  analysed,  histology  showed  PCa  in  113  (113/280,  40%).  Overall  DW-
MRI sensitivity,  speciﬁcity  and  accuracy  for  tumor  detection  were  79—81%,  99—95%  and  92—82%
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for  readers  1  and  2,  respectively  (kappa  test:  0.78).  Of  all,  28  (28/113,  25%)  and  22  (22/113,
20%) tumor  foci  were  not  detected  by  reader  1  and  2  respectively.  These  undetected  tumor
foci had  a  mean  pathological  axial  axis  of  5  mm  (range:  3—15  mm)  and  a  Gleason  score  of  6,  7
(3 +  4),  7  (4  +  3)  and  >  7  in  15/28  (54%),  9/28  (32%),  3/28  (10%)  and  1/28  (4%)  of  cases  for  reader
1, and  in  11  (50%),  5  (23%),  5  (23%)  and  1  (4%)  of  cases  for  reader  2.
Conclusion:  A  normal  b-2000  DW-MRI  at  3-T  may  miss  small  tumors  without  or  with  a  minor
Gleason  4  component.
©  2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
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1t  is  now  established  that  up  to  30%  of  prostate  cancers  (PCa)
etected  by  sextant  transrectal  ultrasound  (TRUS)-guided
iopsies  have  a  small  volume,  are  well  differentiated,  and
ay  not  be  considered  for  radical  treatment  [1].  Some
esearchers  suggested  that  over-diagnosis  of  potentially
ndolent  tumors  may  lead  to  radical  over-treatment  [2].
onversely,  fear  of  missing  and/or  underestimating  tumor
ggressiveness  [3]  often  leads  to  repeated  biopsies  and  sat-
ration  biopsies  [4],  which  induce  a  substantial  increase  in
orbidity,  mainly  represented  by  haemorrhage  and  prostati-
is,  particularly  in  patients  with  no  cancer  [5].  Therefore,  it
ecomes  legitimate  to  identify  men  with  clinical  signiﬁcant
Ca  and  avoid  detection  of  indolent  tumors  by  unnecessary
iopsies.
Patients  with  suspected  PCa  can  beneﬁt  of  power
oppler  ultrasound,  elastography  and  dynamic  contrast-
nhanced  magnetic  resonance  imaging  (MRI)  [6—10].
ecently,  diffusion-weighted  MR  imaging  (DW-MRI)  has
merged  as  an  accurate  tool  that  signiﬁcantly  improved
Ca  detection  and  characterization  of  multiparametric-MRI
mp-MRI)  [11,12].  Recently,  the  use  of  ultra-high  b-values
W-MRI  (≥  1500  s/mm2),  by  increasing  the  weighting  of  the
iffusion  sequence,  has  demonstrated  a  higher  accuracy
or  PCa  detection  than  b-value  of  1000  s/mm2 [13—16].  On
he  other  hand,  some  researchers  suggested  that  tumor
ggressiveness  was  inversely  correlated  to  the  value  of  the
pparent  diffusion  coefﬁcient  (ADC)  [17].  Indeed,  impeded
iffusion  increases  with  cellular  density,  which  induces  a
roportional  decrease  in  the  ADC.  Assuming  that  high  Glea-
on  grade  tumors  have  higher  cellular  density,  the  ADC  of
hese  foci  should  be  expected  to  be  lower  [13,17].  How-
ver,  no  cut-off  value  has  been  clearly  deﬁned  to  predict
he  presence  of  high  Gleason  score  tumors,  ﬁrst  because
f  a  large  overlap  of  ADC  between  low  and  high-grade
umors  (reﬂecting  tumors  histologic  heterogeneity)  [18],
nd  second  because  the  ADC  is  highly  dependent  on  the
W-MRI  protocol  [19].  As  a  result,  ADC  cannot  yet  be
onsistently  used  to  distinguish  low-grade  from  high-grade
umors.
We  hypothesized  that  the  qualitative  assessment  of  DW-
R  images  obtained  with  a  single  b-value  of  2000  s/mm2
b-2000  DW-MRI)  at  3-Tesla  (3  T)  could  increase  the  con-
picuity  of  areas  with  the  highest  cellular  density  and
ifferentiate  benign  from  malignant  tissue.  We  further
ypothesized  that  a  normal  examination  at  ultra-high  b-
alue  (i.e.  the  absence  of  hyperintense  foci),  would  only
iss  small  volume  and/or  low-grade  tumors,  and  could  thus
e  conﬁdently  used  to  avoid  overlooking  aggressive  tumors,
nd  to  avoid  over-diagnosis  of  indolent  tumors.
I
M
wTo  assess  the  accuracy  of  DW-MRI  at  3  T  with  a  b-value  of
000  s/mm2 to  detect  PCa  and  to  describe  the  histological
eatures  of  missed  tumors.
aterials and methods
his  retrospective,  single-centre  study  was  approved  by
ur  institutional  review  board  and  informed  consent  was
aived.  The  MR  imaging  database  of  our  department  was
ueried  to  identify  all  patients  with  clinically  localized
Ca  referred  for  prostate  mp-MRI  at  3-Tesla,  including  an
cquisition  with  a  ultra-high  b-value  (b  =  2000  s/mm2)  and
ubsequently  treated  by  radical  prostatectomy.  From  May
011  through  September  2012  inclusively,  35  patients  with  a
ean  age  of  64  ±  6.2  years  old  were  ultimately  eligible  for
he  study.  Interval  between  DW-MRI  and  surgical  resection
as  less  than  3  months  in  all  patients  and  no  patient  received
ormonal  deprivation  before  surgery.
R imaging Protocol
ll  patients  underwent  a prostate  mp-MRI  using  a  3-T
ystem  (Magnetom  Skyra®, Siemens  Healthcare,  Erlangen,
ermany)  with  an  8  channels  anterior  phased-array  sur-
ace  coil  and  an  18-channel  phased-array  posterior  spine
oil.  Patients  were  imaged  in  supine  position  after  rectal
reparation  to  eliminate  gas  and  faeces  (sodium  bispho-
phate  and  sodium  phosphate  enema).  An  antispasmodic
gent  (Phloroglucinol,  80  mg)  was  injected  intravenously.
iffusion-weighted  MR  images  were  performed  in  the
xial  plane  and  included  ﬁrst  a  sequence  with  three
iffusion  gradient  factors  (b-values  = 50,  400,  800  s/mm2)
or  measurement  of  the  ADC  value  and  second,  a  sep-
rate  acquisition  with  a  single  ultra-high  b-value  of
000  s/mm2. Diffusion-weighted  MR  images  were  acquired
fter  the  T2-weighted  (T2-W)  MRI  and  prior  to  gadolinium
ntravenous  injection.  Ultra-high  b-value  (b  = 2000  s/mm2)
W-MRI  images  were  acquired  with  a  Fast  Spin-Echo  Echo-
lanar  imaging  sequence  with  the  following  parameters:
pectral  adiabatic  fat  saturation;  TR/TE:  5200  ms/70  ms;
lice  thickness:  1.6  mm,  no  gap;  ﬁeld  of  view:  240  ×  160;
atrix  size:  75  ×  100;  number  of  excitations:  12;  voxel  size:
.6  ×  1.6  ×  3  mm;  acquisition  time:  2  min  15  s.mage analysis
R  images  were  analyzed  using  a  commercially  available
orkstation  (Siemens  Healthcare,  Forsheim,  Germany)  by
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sFigure 1. Diagram of the prostate octant division to assign a site
right or left lobe (R and L), base (1), mid-lobe (2) and apex (3) and
two  independent  readers  (one  fourth  year  radiology  resident
and  one  radiologist  with  20  years  of  experience  in  interpre-
ting  prostate  MR  images),  aware  of  the  diagnosis  of  PCa,
but  blinded  to  the  results  of  biopsy  and  surgical  pathologi-
cal  ﬁndings.  The  two  readers  analyzed  source  b-2000  DW-MRI
and  were  blinded  to  results  of  the  other  MR  sequences.  Loca-
tion  of  all  high  signal  intensity  foci  was  recorded  according
to  the  biopsy  scheme  used  in  our  department  (Fig.  1).  A
high  intensity  area  was  deﬁned  by  comparison  with  the  sig-
nal  intensity  of  the  rest  of  the  prostate  (Figs.  2  and  3).
The  peripheral  zone  was  divided  in  6  sectors  (right  of  left
lobe,  base,  mid-lobe  and  apex)  and  the  transition  zone  was
divided  in  right  and  left  lobe.  Overall  280  sectors  were  eval-
uated.
Pathological examination
After  radical  prostatectomy,  glands  were  ﬁxed  in  formalin
for  at  least  48  hours  and  coated  with  India  ink.  The  glands
were  cut  into  4-mm  sections  perpendicular  to  the  poste-
rior  plane,  separated  in  halves  or  quarters,  depending  of
the  size  of  the  block,  labelled,  embedded  in  parafﬁn,  and
further  sectioned  to  produce  5-m  step  sections  that  were
E
t
c
Figure 2. Elevated PSA serum level in a 58-year-old man  from 3.9 ng/m
A. Diffusion-weighted MRI of the medium prostate gland (TR = 5200 ms; 
high signal intensity is visible in the left peripheral zone (arrow). B. Prost
the mid prostate gland. A 8-mm Gleason score 7 (3 + 4) tumor focus with
Gleason grade 7 (3 + 4) focus with 20% of grade 4 of the right PZ (arrowheach tumor focus. The peripheral zone was divided in six sectors:
nterior zone was divided in two sectors (right and left lobe) (4).
tained  with  hematoxylin  and  eosin.  A  single  experienced
ro-pathologist  (EL),  blinded  to  MR  imaging  ﬁndings,  micro-
copically  reviewed  all  samples  and  performed  a prostate
apping  of  tumor  foci  using  photographs  of  the  macroscopic
ections  as  a  template  with  the  same  scheme  used  for  MR
mages  interpretation.  Each  tumor  focus  surface  was  drawn
n  the  prostate  mapping.  The  total  number,  the  largest  axial
xis  of  tumor  foci  and  their  locations  were  recorded.  An
rea  of  carcinoma  was  considered  to  be  a  separate  focus
f  it  was  separated  from  the  nearest  adjacent  focus  by
 low-power  ﬁeld  diameter  of  4.5  mm  [20]. Each  tumor
ocus  was  graded  according  to  the  modiﬁed  Gleason  sco-
ing  system,  and  the  percentage  of  grade  4  was  recorded
21]. Pathologic  stage  was  determined  according  to  the  2009
umor—node—metastasis  classiﬁcation  for  prostate  cancer
21].
orrelation of MR images and histological
lidesach  pathological  slice  of  the  tumor  mapping  was  matched
o  the  corresponding  MR  image  by  a  separate  observer  in
onsensus  with  the  pathologist,  using  the  veru-montanum
l to 5.94 ng/ml in 6 months with normal digital rectal examination.
TE = 70 ms) in the axial plane obtained at b = 2000 s/mm2. Nodular
ate pathological mapping of the corresponding histological slice of
 30% of grade 4 is present in the left PZ (arrow) as well as a 7-mm
ead), not visible on MRI.
926  M.  Barral  et  al.
Figure 3. Elevated PSA level (6.4 ng/ml) in a 72-year-old man with a non-suspicious digital rectal examination. A and B. Axial DW-MRI at
the mid portion of the prostate. A nodular high signal intensity is visible posteriorly in the right PZ (arrow, A) and anteriorly in the anterior
horn of the left PZ (arrow, B). C. Prostate pathological mapping of the corresponding histological slice of the mid prostate gland. A 8-mm
Gleason score 7 (4 + 3) tumor focus with 60% of grade 4 in the right PZ (black arrow) and a 26-mm Gleason score 7 (3 + 4) tumor focus with
2  Gleason grade 7 (3 + 4) with 30% of grade 4 component is present in the
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Table  1  Clinical  characteristics  of  the  35  patients.
Number  of  cases  (%)
Age  (mean  ±  SD)  64  ±  6.2
Clinical  stage
T1c  24/35  (68%)
T2  11/35  (32%)
Tumor  risk
Low  5/35  (14%)
Intermediate  24/35  (68%)
High  6/35  (18%)
Low risk: PSA level less than 10 ng/ml, Gleason score 6, less
than 33% positive biopsies involving no more than two  adja-
cent sextants. No core with Ca length > 7 mm and total Ca
length < 10 mm. Intermediate risk: PSA level 10—20 ng/ml or
Gleason score 7 (3 + 4) or Gleason 6 without low risk criteria for
tumor length or % positive biopsies. High risk: PSA level more
than 20 ng/ml or Gleason score equal or greater than 7 (4 + 3).
o
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not  detect  22  tumor  foci.  Of  these,  Gleason  score  was  6,  7
(3  +  4),  7  (4  +  3)  and  >  7 in  11  (50%),  5 (23%),  5  (23%)  and  1  (4%)
cases,  respectively.  The  less  experienced  reader  (reader  1)
Table  2  Pathological  ﬁndings  of  113  prostate  tumor  foci
in  35  patients.
Gleason  score  #  of  tumor  foci
(n  =  113),  n  (%)
Mean  diameter
(mm)  ±  SD  [range]
Gleason  6  35  (31)  12.5  ±  7.8  [2—30]0% of grade 4 in the left PZ are visible (white arrow). A third 4 mm
ight TZ (arrowhead), not detected at DW-MR images.
nd  ejaculatory  ducts  as  landmarks.  The  corresponding
leason  score  of  each  MRI  focus  was  assessed,  according
o  its  location  on  the  pathological  slice  and  percentage  of
leason  grade  4  was  calculated.  Gleason  score  and  size  of
ndetected  tumors  on  MRI  were  recorded.  Correlation  was
erformed  using  the  same  sector  segmentation  as  that  used
or  MRI  interpretation.  Evaluation  of  size  and  Gleason  grade
f  undetected  tumors  was  performed  only  for  the  worst
eader  regarding  the  sensitivity  of  detection.
tatistical analysis
ensitivity,  speciﬁcity  and  accuracy  of  tumor  detection  were
xpressed  in  percentage  with  exact  95%  conﬁdence  interval
CI)  from  the  binomial  distribution.  Agreement  in  PCa  foci
etection  between  the  two  readers  was  assessed  with  the
ohen  kappa  value  (poor  agreement:  0.00—0.20;  fair  agree-
ent:  0.21—0.40;  moderate  agreement:  0.41—0.60;  good
greement:  0.61—0.80;  excellent  agreement:  0.  81—0.99,
erfect  agreement:  1.
esults
atient characteristics
atient  characteristics  are  summarized  in  Table  1  and  patho-
ogical  ﬁndings  are  listed  in  Table  2.  Of  the  280  sectors
nalyzed,  113  tumor  foci  were  identiﬁed.  Gleason  score
as  ≥  7  in  78  cases  78/113;  69%)  and  <  7  in  35  cases  (35/113;
1%).  Mean  largest  axial  tumor  diameter  was  17.1  ±  8.24  mm
range:  2—30  mm].  Mean  size  of  Gleason  6  tumor  foci
12.5  ±  7.8  mm)  was  signiﬁcantly  lower  than  that  of  each
ategory  of  higher  Gleason  score  foci  (p  =  0.01).  Nine  (8/113,
%)  tumor  foci  were  located  in  the  TZ  and  105  (105/113,  92%)
n  the  PZ.RI results
esults  of  MR  images  analysis  of  both  readers  are  reported
n  Table  3.  The  overall  sensitivity,  speciﬁcity  and  accuracyf  b-2000  DW-MRI  for  cancer  detection  were  79.1%,  99.4%,
nd  92.2%  for  reader  1  and  80.7%,  95.1%,  and  82.3%  for
eader  2  with  a  good  agreement  (Kappa  value  = 0.78,  95%
I:  0.69—0.86).  The  more  experienced  reader  (reader  2)  didGleason  7  (3  +  4)  34  (30)  17.4  ±  7.8  [3—30]
Gleason  7  (4  +  3)  35  (31)  19.3  ±  7.6  [4—30]
Gleason  >  7  9  (8)  18.6  ±  9.8  [4—30]
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Table  3  Sensitivity,  speciﬁcity  and  accuracy  of  DW-MRI  with  a  b-value  of  2000  s/mm2 for  prostate  cancer  detection.
b-2000  DW-MRI  Sensitivity  (%)
95%  CI
Speciﬁcity  (%)
95%  CI
Accuracy  (%)
95%  CI
Reader  1  79.1  [69.7—86.8] 99.4  [96.8—99.9] 92.2  [88.4—95.1]
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pReader  2  80.7  [68.3—86.8] 
did  not  detect  28  tumor  foci  (Fig.  2).  Of  these,  Gleason  score
was  6,  7  (3  +  4),  7  (4  +  3)  and  >  7  in  15  (54%),  9  (32%),  3  (10%)
and  1  (4%)  cases,  respectively.  For  both  readers,  Gleason  6
missed  tumors  had  a  mean  large  diameter  of  13.4  ±  8.9  mm
[range:  2—30  mm].  Of  the  9  missed  Gleason  score  7  (3  +  4)
foci  (5  were  similar  for  both  reader,  and  4  additionally  were
not  detected  by  reader  1),  percentage  of  grade  4  was  less
than  30%  in  all  cases.  At  pathological  examination,  the  mean
size  of  these  foci  was  5  mm  [range:  3—15  mm].  Of  the  44
highest-grade  tumors  (Gleason  score  ≥  7  (4  +  3)),  b-2000  DW-
MRI  missed  6  of  them  (4/44,  9%  for  reader  1  and  6/44,  13%
for  reader  2),  which  had  a  large  axis  of  6,  2,  4,  3,  1  and
4  mm,  respectively.
Discussion
Our  study  conﬁrms  the  high  accuracy  of  b-2000  DW-MRI
used  alone  for  detection  of  PCa,  with  a  sensitivity  of  0.79
that  is  consistent  with  the  values  reported  in  other  series
[18—26].  It  seems  thus  that  visual  assessment  of  b-2000  DW-
MRI  at  3  T  is  accurate  to  predict  the  presence  of  PCa.  In
addition,  our  study  showed  that  an  excellent  agreement
was  found  between  a  junior  radiologist  and  a  highly  experi-
enced  reader.  A  good  reproducibility  of  the  test  may  thus  be
expected  across  centres,  contributing  to  an  accurate  and
standardized  reading  of  MR  examinations,  related  to  the
conspicuity  of  high  signal  intensity  tumor  foci.
Our  results  suggest  that  detection  of  any  bright  area  on
ultra-high  b-value  DW-MRI  should  trigger  the  reading  of  the
other  mp-MRI  acquisitions  to  conﬁrm  the  suspicion  of  tumor
and  evaluate  the  MR  tumor  stage.  Conversely,  despite  of
the  small  size  of  our  study  population,  it  can  probably  be
assumed  that  the  absence  of  any  bright  focus  on  b-2000  DW-
MRI  at  3-Texcludes  the  presence  of  a  PCa  with  a  large  axial
axis  <  6  mm  with  >  30%  Gleason  grade  4  component,  without
the  need  of  being  aware  of  imaging  ﬁndings  of  the  other  MRI
sequences.  Therefore,  b-2000  DW-MRI  at  3-T  could  play  a
role  of  ﬁlter  for  the  detection  of  aggressive  tumors  (Gleason
score  >  7(4  +  3)).  Only  9%  of  them  (4/44),  all  with  a  transverse
axis  <  5  mm,  were  overlooked  because  they  did  not  show  a
bright  signal  on  DW-MRI.  Moreover,  most  of  the  undetected
Gleason  score  7  tumors  contained  no  more  than  30%  of  Glea-
son  grade  4.  As  a  result,  a  negative  b-2000  DW-MRI  at  3-T
may  indicate  either  the  absence  of  malignancy  or  the  pres-
ence  of  a  low-volume  and  well-differentiated  tumor,  with
less  than  30%  of  grade  4  in  most  cases.  These  results  are  in
accordance  with  those  of  studies  using  DW-MRI  with  multiple
b-values  and  ADC  mapping  [24—26].  In  a  recent  study,  Bratan
et  al  found  on  multivariate  analysis  that  histological  char-
acteristics  and  tumoral  volume  inﬂuenced  PCa  detection,
but  conversely  neither  the  coil  type  nor  magnetic  ﬁeld  were
associated  with  PCa  conspicuity  [27].  However,  in  this  study,
i
t
m
S95.1  [90.6—97.8] 82.3  [77.3—86.7]
here  was  no  direct  comparison  in  the  same  patients  at  1.5-T
ersus  3-T  or  with  versus  without  an  endorectal  coil.  Indeed,
hey  aggregated  data  from  three  different  MR  systems  using
ifferent  ﬁeld  strength  and  coil  conﬁguration,  which  induces
eterogeneity  in  the  series  and  does  not  permit  to  draw
eﬁnite  conclusion.
In addition,  it  can  be  suggested  from  our  data  that  ultra-
igh  DW-MRI  at  3-T  may  be  included  in  the  work-up  of  a
ewly  diagnosed  PCa,  especially  in  low  risk  patients  eligi-
le  for  active  surveillance  protocols,  either  at  the  time  of
atient  inclusion  or  during  follow-up  to  suspect  the  presence
f  aggressive  Gleason  grade  components.  The  presence  of
 bright  focus  may  indicate  repeat-targeted  biopsies  using
ither  TRUS-MR  registration  systems  or  MR  imaging  guidance
28,29].
It can  be  noted  from  our  results,  that  both  readers  inde-
endently  found  a  very  high  speciﬁcity  (0.95—0.99),  higher
han  that  reported  by  Ueno  et  al.  (0.65)  at  3  T  [21].  Speci-
city  may  indeed  be  lower  in  the  transition  zone,  as  bright
oci  in  this  area  on  DW-MRI  may  be  related  to  stromal
yperplasic  nodules.  The  low  number  (8%)  of  TZ  tumor  foci
ncluded  in  our  series  may  explain  the  overall  high  speci-
city  of  b-2000  DW-MRI  at  3T  alone.  We  also  elected  not  to
eport  the  T2W-MRI  ﬁndings,  which  may  modify  the  speci-
city  if  combined  with  DW-MRI  ﬁndings.  The  reason  is  that
he  objective  of  this  study  was  not  to  evaluate  the  accu-
acy  of  combined  T2  W  and  DW-MRI  for  PCa  detection,  but
o  assess  if  DW-MRI  with  a  b-value  of  2000  s/mm2 could  rep-
esent  a  ﬁlter  to  detect  only  aggressive  tumors.  Finally  the
igh  speciﬁty  found  in  our  study  may  also  be  inﬂuenced  by
he  fact  that  both  readers  were  aware  of  the  presence  of
Ca.
Recent  reﬁnements  in  coils  and  software  allow  to  beneﬁt
rom  the  higher  signal-to-noise  ratio  at  3-T  that  improves  the
erformances  of  DW-MRI  at  ultra-high  b-values.  However,
ne  could  argue  that  only  few  3-T  magnets  are  available,
hus  limiting  the  widespread  use  of  ultra-high  b-value  DW-
RI  which  is  difﬁcult,  if  not  impossible  to  acquire  with  many
urrent  1.5-T  platforms,  owing  to  the  low  signal-to-noise
atio  at  b-values  >  1500  s/mm2.  However,  a recent  article
y  Maas  et  al.  [28]  showed  that  computed  DW-MRI  at  b-
alues  >  1400  s/mm2, calculated  from  measured  images  with
-values  between  0  and  800  s/mm2,  yielded  a  contrast-to-
oise  ratio  equal  to  that  measured  with  DW-MRI  at  a  b-value
f  1400  s/mm2.  Would  this  ﬁnding  be  conﬁrmed  at  1.5-T  on
ecent  MRI  platforms,  it  could  represent  a  clinical  aid  as
ccurate  as  that  of  an  acquired  b-value  of  2000  s/mm2.
This  study  has  several  limitations.  First,  we  did  not  com-
are  the  accuracy  of  ADC  map,  T2-W  MR  images  or  DCE-MR
mages  to  that  of  b-2000  DW-MRI.  However,  these  data  and
heir  limitations  have  already  been  reported  [21],  and  the
ain  objective  of  our  study  was  not  to  further  conﬁrm  them.
econd,  since  every  patient  was  a  candidate  for  surgery,
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nly  patients  with  clinically  localized  disease  were  included.
hird,  it  remains  difﬁcult  to  perform  an  optimal  correla-
ion  of  MR  images  with  pathological  slides  because  prostate
hape  and  volume  of  the  specimens  may  change  while  being
xed  with  formalin.  Moreover,  we  did  not  use  any  speciﬁc
evice  to  ensure  a  consistent  slice  thickness  during  patho-
ogical  processing  [30,31].  Also,  we  did  not  correlate  MRI  and
athological  slices  in  a  3D  fashion.  Speciﬁc  registration  soft-
are  is  currently  under  development  but  is  not  commercially
vailable  [32—35].  All  these  limitations  in  our  technique  may
ave  induced  a  slight  mismatch  of  tumor  foci  localization.
inally,  the  small  number  of  patient  does  not  allow  us  to
raw  deﬁnite  conclusion  and  large-scale  prospective  multi-
entric  studies  should  be  conducted  to  conﬁrm  our  results.
onclusion
n  conclusion,  b-2000  DW-MR  images  at  3  T  may  represent
n  effective  tool  to  rule  out  the  presence  of  a  >  5-mm  high-
rade  PCa.  However,  further  clinical  work  is  necessary  to
stablish  the  true  negative  predictive  value  of  b-2000  DW-MR
mages  at  3T  before  this  examination  could  be  recommended
s  a  screening  test  before  biopsy  or  for  active  surveillance
f  PCa.
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